Research work · 2021
Analysis of Female Enrollment and Participant Sex by Burden of Disease in US Clinical Trials Between 2000 and 2020
JAMA Network Open
Abstract
Key Points Question How is disease burden associated with female representation in US-based clinical trials, and how are disease category and other clinical trial features associated with female representation in clinical trials? Findings In this cross-sectional study of 20 020 clinical trials enrolling more than 5 million participants between 2000 and 2020, clinical trials in the fields of oncology, neurology, immunology, and nephrology had the lowest female participant representation relative to corresponding disability-adjusted life-years. Clinical trials in cardiology and pediatrics had the greatest negative associations with female enrollment, and clinical trials of preventive interventions had a positive association. Meaning This study’s findings suggest that sex bias persists within clinical trials, with male and female participants underrepresented in different areas of research.